Krystal Biotech Inc (KRYS)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 65,695 | -109,727 | -145,196 | -68,275 | -32,999 |
| Total assets | US$ in thousands | 1,055,840 | 818,355 | 558,450 | 626,295 | 310,844 |
| Operating ROA | 6.22% | -13.41% | -26.00% | -10.90% | -10.62% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $65,695K ÷ $1,055,840K
= 6.22%
Krystal Biotech Inc's operating return on assets (operating ROA) showed fluctuations over the past five years. The operating ROA was negative in 2020 (-10.62%), 2021 (-10.90%), 2022 (-26.00%), and 2023 (-13.41%), indicating that the company's operating profits were insufficient to cover its assets during those years. However, in 2024, the operating ROA turned positive at 6.22%, signaling an improvement in the company's ability to generate operating profits relative to its assets. Overall, the negative trend in the operating ROA over the previous years might suggest challenges faced by Krystal Biotech Inc in effectively utilizing its assets to generate operating income. The positive turn in 2024 could indicate potential positive developments in the company's operational efficiency and profitability.
Peer comparison
Dec 31, 2024